Sequencing Of Agents And Combination Of Treatment Options For Bladder Cancer

AUAUniversity - A podcast by American Urological Association

Categories:

Co-Host: Yair Lotan, MD At the conclusion of these activities, participants will be able to: 1. Evaluate treatment plans including the sequencing and combination of treatment options for individual patients. 2. Facilitate discussions with patients and caregivers regarding of bladder cancer treatment options. CME Available: auau.auanet.org/node/26075 This educational series is supported by independent educational grants from: Amgen Astellas AstraZeneca Bristol-Myers Squibb Genomic Health Merck Pfizer, Inc. Sanofi Genzyme UroGen Pharma